Filing Details

Accession Number:
0001140361-17-003553
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-30 21:39:04
Reporting Period:
2017-01-26
Filing Date:
2017-01-30
Accepted Time:
2017-01-30 21:39:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1301501 Achaogen Inc AKAO Pharmaceutical Preparations (2834) 680533693
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654446 Blake Wise C/O Achaogen, Inc.
7000 Shoreline Court, #371
South San Francisco CA 94080
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-01-26 1,431 $16.78 46,687 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 143,053 Indirect See Footnote
Footnotes
  1. The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units of the Issuer.
  2. Includes 33,075 Restricted Stock Units and 3,000 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2016.
  3. The shares are held directly by the Blake A. Wise Living Trust.